Abstract P496: Clot Characteristics in Mechanical Thrombectomy: Interim Analysis of the EXCELLENT Registry

IntroductionRed blood cell (RBC) rich vs fibrin rich clots have different mechanical properties and greater knowledge about clot composition in the context of clinical, imaging, and procedural factors in mechanical thrombectomy (MT) may help with procedural optimization. The EXCELLENT Registry (NCT0...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 52; no. Suppl_1; p. AP496
Main Authors Nogueira, Raul, Siddiqui, Adnan H, De Meyer, Simon F, Doyle, Karen, Fiehler, Jens, Hacke, Werner, Hanel, Ricardo, Liebeskind, David S, Zaidat, Osama O, Haussen, Diogo C, Humphries, William, Woodward, Keith B, Jabbour, Pascal M, Dashti, Shervin R, Bozorgchami, Hormozd, Levy, Elad, Schirmer, Clemens M, Taqi, Muhammad A, De Leacy, Reade A, Boor, Stephan, Hussain, M. Shazam, Puri, Ajit S, Estrade, Laurent, Andersson, Tommy
Format Journal Article
LanguageEnglish
Published Lippincott Williams & Wilkins 01.03.2021
Online AccessGet full text
ISSN0039-2499
1524-4628
DOI10.1161/str.52.suppl_1.P496

Cover

More Information
Summary:IntroductionRed blood cell (RBC) rich vs fibrin rich clots have different mechanical properties and greater knowledge about clot composition in the context of clinical, imaging, and procedural factors in mechanical thrombectomy (MT) may help with procedural optimization. The EXCELLENT Registry (NCT03685578) is a prospective, global, multi-center, observational registry of EmboTrap as the first line MT device for large vessel occlusion (LVO). We present an interim analysis of clot collected per pass in the registry. MethodsFive hundred thirty-three clot specimens from 376 subjects were collected by 20 sites and sent for analysis by independent Central Labs under standardized protocol. Analysis was interrupted by COVID-19, but the labs were fully operational as of June 2020 and on track to deliver results for 300 subjects in Q4. At the time of abstract submission, composition data for 234 clots from 163 subjects was available. All available data will be presented at the time of the conference. ResultsCardioembolic etiology (n=100) was associated with lower RBC (40.2 vs 47.2%) and higher fibrin content (31.7 vs 26.7%) compared to large artery disease (n=12). Hyperdense/vessel susceptibility sign (78+, 24-, per independent imaging core lab) corresponded to higher mean RBC content (44.4 vs 34.9%). Treatment with IV tPA (60+, 91-) had no clear impact on clot composition (42.3 vs 40.6% RBC; 30.4 vs 30.0% fibrin). Notably, clots retrieved with the first 2 passes of were more RBC rich (42.1 vs 28.0%) and clots retrieved in higher passes had a higher average fibrin content (35.5 vs 29.6%) suggesting that higher fibrin content leads to greater refractoriness. ConclusionsClot density/susceptibility on baseline imaging, stroke etiology and number of thrombectomy passes were associated with differential clot composition. These findings may have potential implications for the development of better MT strategies.
ISSN:0039-2499
1524-4628
DOI:10.1161/str.52.suppl_1.P496